PRKACA and hyperlipidemia: The estrogen signaling pathway was regulated by CA binding to HSP90AA1, MMP2, RARA, PRKACA, ESR1, MMP9, and ESR2 in this present research, which underlies the improvements observed in hyperlipidemia and thrombosis.